The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis

Journal of Infection

Volumn 81, Issue 1, 2020, Pages e13-e20

  Yang, Zhenwei ^a,b   Liu, Jialong ^a,b   Zhou, Yunjiao ^a,b   Zhao, Xixian ^a,b   Zhao, Qiu ^a,b   Liu, Jing ^a,b  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases   (China)

Author keywords

Coronavirus; corticosteroid treatment; COVID 19; Meta analysis

Indexed keywords

CORTICOSTEROID;

BACTERIAL INFECTION; CORONAVIRUS DISEASE 2019; CORTICOSTEROID THERAPY; DISEASE SEVERITY; HUMAN; HYPERGLYCEMIA; HYPOCALCEMIA; HYPOKALEMIA; LENGTH OF STAY; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; SYSTEMATIC REVIEW; BETACORONAVIRUS; CORONAVIRUS INFECTION; PANDEMIC; VIROLOGY; VIRUS PNEUMONIA;

ADRENAL CORTEX HORMONES; BETACORONAVIRUS; CORONAVIRUS INFECTIONS; HUMANS; PANDEMICS; PNEUMONIA, VIRAL;

EID: 85083304902     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2020.03.062     Document Type: Review

References (35)

1. Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:8 (2020 Feb 20), 727–733 PubMed PMID: 31978945. Epub 2020/01/25. eng.
2. Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. 2020:2020.02.07.937862.
3. WHO. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February2020. Available from: https://www.who.int/zh/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020.
4. He F., Deng Y., Li W.Coronavirus disease 2019 (COVID-19): what we know?J Med Virol. 2020 Mar 14. PubMed PMID: 32170865. Epub 2020/03/15. eng.
5. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England) 395:10223 (2020 Feb 15), 497–506 PubMed PMID: 31986264. Epub 2020/01/28. eng.
6. Chan, J.F., Yuan, S., Kok, K.H., To, K.K., Chu, H., Yang, J., et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet (London, England) 395:10223 (2020 Feb 15), 514–523 PubMed PMID: 31986261. Epub 2020/01/28. eng.
7. WHO. WHO Director-General's opening remarks at the Mission briefing on COVID-19 - 19 March 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-mission-briefing-on-covid-19—-19-march-2020.
8. Lu, H., Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends 14:March 16(1) (2020), 69–71 PubMed PMID: 31996494. Epub 2020/01/31. eng.
9. Cruz-Topete, D., Cidlowski, J.A., One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids. NeuroImmuno Modul 22:1-2 (2015), 20–32 PubMed PMID: 25227506. Pubmed Central PMCID: PMC4243162. Epub 2014/09/18. eng.
10. Yam, LY-C, Lau, AC-W, Lai, FY-L, Shung, E., Chan, J., Wong, V., et al. Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong. J Infect 54:1 (2007), 28–39 PubMed PMID: 16542729. Epub 2006/03/15. eng.
11. Arabi, Y.M., Mandourah, Y., Al-Hameed, F., Sindi, A.A., Almekhlafi, G.A., Hussein, M.A., et al. Corticosteroid therapy for critically ill patients with middle east respiratory syndrome. Am J Respir Crit Care Med 197:6 (2018), 757–767 PubMed PMID: 29161116. eng.
12. Stang, A., Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:September(9) (2010), 603–605 PubMed PMID: 20652370. Epub 2010/07/24. eng.
13. Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020, e201585 PubMed PMID: 32031570. eng.
14. Alfaraj, S.H., Al-Tawfiq, J.A., Assiri, A.Y., Alzahrani, N.A., Alanazi, A.A., Memish, Z.A., Clinical predictors of mortality of middle east respiratory syndrome coronavirus (mers-cov) infection: a cohort study. Travel Med Infect Dis 29 (May-Jun 2019), 48–50 PubMed PMID: 30872071. Epub 2019/03/11. eng.
15. Jia, W.D., Deng, X.L., Tang, X.P., Yin, C.B., Zhang, F.C., Yang, Z., et al. [Dose of glucocorticosteroids in the treatment of severe acute respiratory syndrome]. J Southern Medical University 29:November(11) (2009), 2284–2287 PubMed PMID: 19923088. Epub 2009/11/20. chi.
16. Chen, R-C, Tang, X-P, Tan, S-Y, Liang, B-L, Wan, Z-Y, Fang, J-Q, et al. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience. Chest 129:6 (2006), 1441–1452 PubMed PMID: 16778260. eng.
17. Xu, Y., Zhou, L., Xu, M., [Analysis of corticosteroid therapy in 453 patients with SARS]. Chin J Hospital Pharm(02), 2005, 58–59.
18. Wang, P., Li, M.Y., Shi, Y.L., Wang, S.X., Liu, G.F., [Evaluating the effects of different treatments on severe acute respira tory syndrome]. Shanxi Med J(04), 2005, 270–272.
19. Ding, K., Xu, Z.J., Huang, H., Wang, Z., Xu, L.L., Tong, Z.H., et al. [Retrospective analysis of the glucocorticoid treatment in 409 patients with severe acute respiratory syndrome]. Chin J General Pract(03), 2005, 193–194.
20. Auyeung, T.W., Lee, J.S.W., Lai, W.K., Choi, C.H., Lee, H.K., Lee, J.S., et al. The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study. J Infect 51:2 (2005), 98–102 PubMed PMID: 16038758. eng.
21. Wang, Y.Q., Wen, M.H., Chang, M., Ding, Q.H., Zeng, Y., Meng, L., et al. [Investigation of adverse reactions to glucocorticods in 460 SARS patients]. Adv Drug React J(02), 2004, 78–82.
22. Wang, R., Zhou, X.Q., Dong, J., Wei, R., Cao, X.T., Zhou, Y.C., et al. [Effects and adverse drug reactions of mtrisone in the treatment of patients with severe acute respiratory syndrome]. Chin J Clin Pharmacol Therap(09), 2004, 992–996.
23. Qin, Y.Y., [A clinical investigation in 83 cases with severe acute respiratory syndrome]. Chin J Respir Critic Care Med(04), 2003, 15–17.
24. He, R., Liu, Z., Duan, X.F., [Adverse effects associated with corticosteroids therapy in 57 SARS case]. Adv Drug React J(06), 2003, 374–377.
25. Russell, C.D., Millar, J.E., Baillie, J.K., Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet (London, England) 395:February 15(10223) (2020), 473–475 PubMed PMID: 32043983. Epub 2020/02/12. eng.
26. Shang, L., Zhao, J., Hu, Y., Du, R., Cao, B., On the use of corticosteroids for 2019-nCoV pneumonia. Lancet (London, England) 395:February 29(10225) (2020), 683–684 PubMed PMID: 32122468. Epub 2020/03/04. eng.
27. Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory medicine, 2020 February 18 PubMed PMID: 32085846. Epub 2020/02/23. eng.
28. Montón, C., Ewig, S., Torres, A., El-Ebiary, M., Filella, X., Rañó, A., et al. Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study. Eur Respir J 14:July(1) (1999), 218–220 PubMed PMID: 10489855. Epub 1999/09/18. eng.
29. Gonzalo, J.A., González-García, A., Martínez, C., Kroemer, G., Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo. J Exp Med 177:May 1(5) (1993), 1239–1246 PubMed PMID: 8478606. Pubmed Central PMCID: PMC2191024. Epub 1993/05/01. eng.
30. Wilkinson, T.M., Li, C.K., Chui, C.S., Huang, A.K., Perkins, M., Liebner, J.C., et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 18:January 29(2) (2012), 274–280 PubMed PMID: 22286307. Epub 2012/01/31. eng.
31. Lee, N., Allen Chan, K.C., Hui, D.S., Ng, E.K.O., Wu, A., Chiu, R.W.K., et al. Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients. J Clin Virol 31:4 (2004), 304–309 PubMed PMID: 15494274. eng.
32. Ling, Y., Xu, S-B, Lin, Y-X, Tian, D, Zhu, Z-Q, Dai, F-H, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl), 2020 10.1097/CM9.0000000000000774. PubMed PMID: 32118639. eng.
33. Stockman, L.J., Bellamy, R., Garner, P., SARS: systematic review of treatment effects. PLoS Med, 3(September(9)), 2006, e343 PubMed PMID: 16968120. Pubmed Central PMCID: PMC1564166. Epub 2006/09/14. eng.
34. Ni, Y-N, Chen, G., Sun, J., Liang, B-M, Liang, Z-A, The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis. Crit Care, 23(1), 2019, 99- PubMed PMID: 30917856. eng.
35. Zhao, R., Wang, H., Wang, X., Feng, F., Steroid therapy and the risk of osteonecrosis in SARS patients: a dose-response meta-analysis. Osteoporosis Int 28:March(3) (2017), 1027–1034 PubMed PMID: 27844132. Epub 2016/11/16. eng.